What is the recommended dosage of Bactrim (trimethoprim/sulfamethoxazole) for a patient with a Methicillin-resistant Staphylococcus aureus (MRSA) wound infection and normal renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosage for MRSA Wound Infection

For MRSA wound infections in adults with normal renal function, use trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160/800 mg) twice daily for 7-14 days, with the higher dose (2 DS tablets = 320/1600 mg twice daily) preferred for more extensive or severe infections. 1

Adult Dosing Recommendations

Standard dosing for purulent cellulitis or uncomplicated MRSA wound infections:

  • 1-2 double-strength (DS) tablets orally twice daily 1
  • Each DS tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole 1
  • The higher dose (2 DS tablets = 320/1600 mg BID) is recommended for more serious infections 2

Treatment duration:

  • 7-14 days depending on infection severity and clinical response 1, 3
  • Simple infections may require only 5-10 days 3
  • More complicated infections warrant the full 14-day course 1, 3

Pediatric Dosing

For children, dose based on the trimethoprim component:

  • Trimethoprim 4-6 mg/kg/dose, sulfamethoxazole 20-30 mg/kg/dose orally every 12 hours 1
  • Contraindicated in children under 2 months of age 1

Evidence Quality and Context

The IDSA guidelines provide Level AII evidence supporting TMP-SMX for MRSA skin and soft tissue infections 1. Research comparing standard dose (160/800 mg BID) versus high dose (320/1600 mg BID) found similar clinical resolution rates (75% vs 73%), suggesting either dose is effective, though guidelines favor the higher dose for serious infections 4. A randomized trial demonstrated TMP-SMX achieved 91.9% cure rates for uncomplicated wound infections, comparable to clindamycin 5.

Critical Caveats and Pitfalls

Streptococcal coverage limitation:

  • TMP-SMX has poor activity against beta-hemolytic streptococci 1
  • If streptococcal coverage is needed (non-purulent cellulitis), combine with a beta-lactam (amoxicillin or cephalexin) or use clindamycin instead 1, 3

When antibiotics are actually needed:

  • For simple abscesses, incision and drainage alone may be adequate without antibiotics 1, 3
  • Add antibiotics if: severe/extensive disease, rapid progression, systemic illness signs, comorbidities/immunosuppression, extremes of age, difficult-to-drain locations, septic phlebitis, or failure of drainage alone 1, 3

Pregnancy and allergy considerations:

  • Pregnancy category C/D - not recommended in third trimester 1
  • Contraindicated in sulfa allergy 2

Monitoring Requirements

  • Monitor renal function with prolonged therapy 2
  • Watch for hypersensitivity reactions 2
  • Assess clinical response at 7-14 days to determine if treatment extension is needed 1

Alternative Agents When TMP-SMX Cannot Be Used

If TMP-SMX is contraindicated or ineffective:

  • Clindamycin 300-450 mg orally three times daily (covers both MRSA and streptococci) 1, 3
  • Doxycycline 100 mg orally twice daily (contraindicated under age 8) 1
  • Linezolid 600 mg orally twice daily (expensive but highly effective) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bactrim Dosing for MSSA Step-Down Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of MRSA Skin Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Randomized Trial of Clindamycin Versus Trimethoprim-sulfamethoxazole for Uncomplicated Wound Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016

Related Questions

What is the recommended dosing for trimethoprim (TMP)/sulfamethoxazole (SMX) for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) infections?
What is the recommended dosage of trimethoprim/sulfamethoxazole (TMP/SMX) orally for the treatment of Methicillin-resistant Staphylococcus aureus (MRSA) wound infections?
What is the recommended dose of Bactrim (trimethoprim/sulfamethoxazole) for step-down therapy in a patient with Methicillin-Sensitive Staphylococcus aureus (MSSA) infection?
What is the recommended treatment regimen for Methicillin-resistant Staphylococcus aureus (MRSA) in a wound using Bactrim (trimethoprim/sulfamethoxazole)?
What is the best course of treatment for a 48-year-old male patient with a recurring bilateral hand Methicillin-resistant Staphylococcus aureus (MRSA) infection, previously treated with Bactrim (Trimethoprim/Sulfamethoxazole), Keflex (Cephalexin), and Clindamycin, now being prescribed Linezolid (600 mg twice daily) for 10 days?
What is the differential diagnosis (D/D) for a hypopigmented raised lesion over the cheeks just below the lower eyelids?
What is the best course of treatment for a 14-year-old male patient with a known case of gastric ulcer (positive rapid urease test) and Helicobacter pylori (H. pylori) infection, who presents with increased loose stools and vomiting on day 4, despite initial management with intravenous (IV) fluids for moderate dehydration?
What investigations are recommended for a patient with Congenital Adrenal Hyperplasia (CAH) on fludrocortisone and hydrocortisone therapy?
What is the differential diagnosis and treatment for Pityriasis (skin condition) alba versus Pityriasis versicolor in a young patient presenting with skin patches?
Is long-term use of bacitracin (topical antibiotic) recommended for a patient with chronic blepharitis?
What's the next step for a 3-day-old newborn, born via emergency cesarean section (CS) due to failure of descent, presenting with tachypnea (65-70 breaths per minute) on the 2nd day of life, with normal complete blood count (CBC) and slightly elevated C-reactive protein (CRP) at 3, but otherwise normal signs, good suck, and active?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.